Crossmark

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor

Crossref DOI link: https://doi.org/10.1038/bjc.2014.251

Published Online: 2014-05-27

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nishio, H

Yaguchi, T

Sugiyama, J

Sumimoto, H

Umezawa, K

Iwata, T

Susumu, N

Fujii, T

Kawamura, N

Kobayashi, A

Park, J

Aoki, D

Kawakami, Y
License Information

License valid from 2014-05-27
More Information

Article History

Received: 25 December 2013

Revised: 7 April 2014

Accepted: 14 April 2014

First Online: 27 May 2014

Change Date: 10 June 2014

Change Type: Update

Change Details: This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

Competing interests

: These authors declare no conflict of interest.